PARDES BIOSCIENCES, INC. Quarterly Net Cash Provided by (Used in) Operating Activities in USD from Q3 2020 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
Pardes Biosciences, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q3 2020 to Q1 2023.
  • Pardes Biosciences, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2023 was -$26.5M, a 30.3% decline year-over-year.
  • Pardes Biosciences, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$72M, a 95% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 -$26.5M -$6.17M -30.3% Mar 31, 2023 10-Q 2023-05-05
Q1 2022 -$20.4M -$16.6M -443% Mar 31, 2022 10-Q 2023-05-05
Q1 2021 -$3.75M Mar 31, 2021 10-Q 2022-05-10
Q3 2020 $8K* Sep 30, 2020 10-Q/A 2021-11-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.